Quantum BioPharma Ltd. Proceeds From Borrowings Classified As Financing Activities
Quantum BioPharma Ltd. (QNTM) reported Proceeds From Borrowings Classified As Financing Activities of $2.11 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2026-03-26
- Quantum BioPharma Ltd. proceeds from borrowings classified as financing activities for the quarter ending 2025-12-31 was -$31.37K, a 110.15% decline year-over-year.
- Quantum BioPharma Ltd. proceeds from borrowings classified as financing activities for the quarter ending 2025-09-30 was $34.31K.
- Quantum BioPharma Ltd. proceeds from borrowings classified as financing activities for the quarter ending 2025-06-30 was $1.67M, a 10412.23% increase year-over-year.
- Quantum BioPharma Ltd. proceeds from borrowings classified as financing activities for the quarter ending 2025-03-31 was $443.53K, a 54.57% increase year-over-year.
| Period end | Proceeds From Borrowings Classified As Financing Activities 3 month | Proceeds From Borrowings Classified As Financing Activities 6 month | Proceeds From Borrowings Classified As Financing Activities 9 month | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$31.37K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $2.94K derived: sum of 2 quarters · filed 2026-03-26 | $1.67M derived: sum of 3 quarters · filed 2026-03-26 | $2.11M 20-F · filed 2026-03-26 |
| 2025-09-30 | $34.31K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $1.70M derived: sum of 2 quarters · filed 2025-11-06 | $2.14M 6-K · filed 2025-11-06 | $2.45M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $1.67M derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $2.11M 6-K · filed 2025-08-07 | $2.42M derived: sum of 3 quarters · filed 2026-03-26 | $2.12M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $443.53K 6-K/A · filed 2025-06-16 | $752.66K derived: sum of 2 quarters · filed 2026-03-26 | $449.86K derived: sum of 3 quarters · filed 2026-03-26 | $465.72K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $309.14K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $6.34K derived: sum of 2 quarters · filed 2026-03-26 | $22.19K derived: sum of 3 quarters · filed 2026-03-26 | $309.14K 20-F · filed 2026-03-26 |
| 2024-09-30 | -$302.80K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$286.94K derived: sum of 2 quarters · filed 2025-11-06 | $0.00 6-K · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | $15.86K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $302.80K 6-K · filed 2025-08-07 | $302.80K derived: sum of 3 quarters · filed 2026-03-26 | $302.80K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | $286.94K 6-K/A · filed 2025-06-16 | $286.94K derived: sum of 2 quarters · filed 2026-03-26 | $286.94K derived: sum of 3 quarters · filed 2026-03-26 | |
| 2023-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 20-F · filed 2026-03-26 | |
| 2023-09-30 | $0.00 derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $0.00 6-K · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 6-K/A · filed 2024-08-19 |